3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Lymphoma, Follicular
2
Pulmonary Disease, Chronic Obstructive
1
Myasthenia Gravis
1
Asthma
1
Interventions
Rituximab
7
Pyridostigmine Bromide
5
Prednisone
5
efgartigimod alfa
4
Hizentra
4
telitacicept
3
Immunoglobulins, Intravenous
3
Cyclophosphamide
3
Azathioprine
3
thymoglobulin
2
fludarabine
2
Thymectomy
2
Steroids
2
Mycophenolic Acid
2
Data Collection
2
Blood Specimen Collection
2
zilucoplan
1
tofacitinib
1
tocilizumab
1
talquetamab
1
sargramostim
1
rozanolixizumab
1
prednylidene
1
gamma-Globulins
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
bu-zhong-yi-qi-tang
1
apraclonidine
1
Walk Test
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Myasthenia Gravis
×
Albuterol
×
Clear all
NCT03914638
2020-04-06
BETA-MG
University of Aarhus
Phase 2/3
Unknown
30 enrolled